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Staphylococcus  
aureus Carrying 
mecC Gene in  
Animals and Urban 
Wastewater, Spain
To the Editor: A new methicillin 
resistance mechanism gene, a diver-
gent mecA homologue named mecC 
(formerly mecA
LGA251
), was recently 
described in Staphylococcus aureus 
(1). Methicillin-resistant S. aureus 
(MRSA) isolates carrying mecC have 
been recovered from humans, rumi-
nants, pets, and other animals such 
as rats, seals, and guinea pigs (1–3). 
It has been suggested that mecC-car-
rying MRSA isolates might not be de-
tected by using MRSA selective me-
dia (4). For mecC-carrying S. aureus 
isolates, cefoxitin MICs of 4–64 mg/L 
have been demonstrated (1–2,4), val-
ues that would normally include sus-
ceptible isolates, according to the epi-
demiologic cutoff value established by 
the European Committee on Antibi-
otic Susceptibility Testing (EUCAST; 
www.eucast.org). mecC-carrying S. 
aureus isolates have been classified 
as heteroresistant (5), and MICs can 
be affected by the drug-susceptibility 
testing method used (1,5).
These observations led us to 
retrospectively investigate the pres-
ence of mecC gene in a set of 361 
mecA-negative S. aureus isolates 
collected during 2009–2012 (Table), 
independently of their susceptibility 
to cefoxitin. Isolates were recovered 
from healthy carriers in livestock (n 
= 39), from wild animals (n = 254), 
and from wastewater (effluents) from 
an urban sewage plant (n = 68). Spe-
cific amplification of the mecC gene 
was performed as described (6). The 
mecC-carrying S. aureus isolates were 
tested by broth microdilution using 
Microtiter EUST plates (Trek Diag-
nostic Systems, East Grinstead, UK) 
for susceptibility to benzylpenicillin, 
cefoxitin, chloramphenicol, cipro-
floxacin, clindamycin, erythromycin, 
florfenicol, fusidic acid, gentamicin, 
kanamycin, linezolid, mupirocin, ri-
fampin, sulfamethoxazole, strepto-
mycin, quinupristin-dalfopristin, tet-
racycline, thiamulin, trimethoprim, 
and vancomycin. Additionally, sus-
ceptibility to oxacillin was determined 
by using microScan Gram Positive 
Combo panel 37 (Siemens, Erlangen, 
Germany). MICs were interpreted ac-
cording to EUCAST epidemiologic 
cutoff values.
mecC was detected in a total of 4 
isolates from wild boar (n = 1), fallow 
deer (n = 2), and urban wastewater (n 
= 1); these isolates represent 1% of 
the 361 tested isolates. The 3 isolates 
recovered from animals were suscep-
tible to all antimicrobial drugs tested 
other than β-lactams and to oxacillin 
(MICs 0.5–1 mg/L) but were resistant 
to penicillin (MICs 0.5–2 mg/L). Two 
of the isolates were resistant to cefoxi-
tin (MICs 8 and 16 mg/L) and the third 
was susceptible (MIC 4 mg/L). The 
wastewater isolate was resistant to 
penicillin (MIC 2 mg/L) and erythro-
mycin (MIC 16 mg/L) and susceptible 
to all other antimicrobial drugs tested, 
including cefoxitin (MIC 4 mg/L) and 
oxacillin (MIC ≤0.25 mg/L).
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Previous studies have described 
mecC-positive isolates as susceptible 
to all antimicrobial drugs tested except 
β-lactams (2,3), although sporadic re-
sistance to fluoroquinolones has been 
found (4,7). We additionally found 
erythromycin resistance in 1 mecC-
carrying S. aureus isolate. For the 4 
mecC-carrying S. aureus isolates we 
detected, MICs of oxacillin were in-
terpreted as susceptible, and 2 isolates 
were susceptible to cefoxitin accord-
ing to EUCAST guidelines, findings 
that agree with previous reports (1–
2,4). Thus, mecC presence is not al-
ways linked to resistance phenotypes 
for cefoxitin or oxacillin; such unclear 
findings could hinder the detection of 
mecC-carrying isolates.
We further characterized the 
4 mecC-carrying S. aureus iso-
lates by spa typing and detection of 
Panton-Valentin leukocidin (PVL) 
toxin genes (6,8). Multilocus se-
quence typing (MLST) was per-
formed according to Enright et al. 
(9) by using self-designed prim-
ers arc (down 5′-CGATTTGTT-
GTTGATTAGGTTC-3′), tpi (up 
5′-CATTAGCAGATTTAGGCGT-
TA-3′), and yqiL (down 5′-GATTG-
GYTCACCTTTRCGTTG-3′). All 
4 isolates were PVL negative. The 
3 animal isolates were assigned to a 
new spa type (t11212) and to clonal 
complex (CC) 425 and sequence type 
(ST) 425 (Table). ST425 has been 
previously associated with mecC-
carrying S. aureus isolates in cattle 
and humans (1–2); the animals we 
sampled were from a game estate and 
may have had contact with cattle and 
with urban wastewater. The waste-
water isolate was assigned to spa 
type t843 and to a new allelic profile, 
ST2676, in CC130 (Table). ST2676 
represents a single-locus variant of 
ST130 carrying a different allele for 
the gene aroE. MRSA isolates of 
CC130 have been associated with 
humans and animals (1–4,6). This 
result indicates that mecC-carrying 
S. aureus isolates can be found in ur-
ban wastewater, which may act as an 
environmental reservoir, as has been 
demonstrated for mecA-carrying 
S. aureus (10).
In conclusion, we detected the 
methicillin resistance mechanism gene 
mecC in nonclinical S. aureus isolates 
from animals and urban wastewater in 
Spain. Although our data indicate that 
the frequency of this resistance mech-
anism is low, this gene appears to be 
expanding to new areas. Prospective 
studies should be performed to evalu-
ate epidemiologic changes and to ana-
lyze the genetic lineages that carry this 
resistance mechanism.
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Table.	Testing	of	Staphylococcus aureus isolates	for	presence	of	methicillin	resistance	mechanism	gene	mecC,	Spain* 
Isolate	source 
Year(s)	of	
isolation 
No.	mecC-positive	
isolates spa type MLST CC 
Antimicrobial	
resistance	profile 
Livestock,	n	=	39       
 Cattle,	n	=	5 2011 0     
 Fattening	pigs,	n	=	34 2009,	2011 0     
Wild	animals,	n	=	254       
 Eurasian	griffon	vulture,	n	=	2 2011 0     
 Fallow	deer,	n	=	2 2012 2 t11212 ST425 CC425 PEN,	FOX 
   t11212 ST425 CC425 PEN 
 Iberian	ibex,	n	=	39 2009–2010 0     
 Mouflon,	n	=	2 2009 0     
 Red	deer,	n	=	61 2009–2011 0     
 Wild	boar,	n	=	148 2009–2011 1 t11212 ST425 CC425 PEN,	FOX 
Urban	wastewater,	n	=	68 2011 1 t843 ST2676 CC130 PEN,	ERY 
*MLST,	multilocus sequence	typing;	ST,	sequence	type;	CC,	clonal	complex;	PEN,	benzylpenicillin;	FOX,	cefoxitin;	ERY,	erythromycin. 
 
1Current	affiliation:	Innovación	en	Gestión	
y	 Conservación	 de	 Ungulados	 S.L.,	
Cáceres,	Spain.
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Schmallenberg  
Virus Antibodies  
in Adult Cows  
and Maternal  
Antibodies in Calves
To the Editor: Schmallenberg 
virus (SBV), a novel orthobunyavirus 
that is transmitted by Culicoides spp. 
biting midges, spread through herds 
of ruminants across Europe during 
2011–2013. The virus reached as far 
as Finland in the north, the Republic 
of Ireland in the west, Turkey in the 
east (1), and Spain in the south. The 
clinical effect of SBV infection in ru-
minant livestock appears to be limited 
(2), and a vaccine to prevent the in-
fection has been developed (3). There 
are no data to refute the assumption 
that natural SBV infection results in 
long-term immunity, as was seen ear-
lier with natural infection of cattle 
with bluetongue virus serotype 8 (4). 
Newborn calves acquire passive im-
munity by ingestion and absorption of 
antibodies present in colostrum. Pas-
sive immunity can, however, block the 
production of serum antibodies when 
vaccine is administered to calves that 
have maternally derived antibodies 
(5). To determine the titers and persis-
tence of SBV antibodies in adult cows 
and the decay of maternal antibodies 
in calves over time, we studied a herd 
of cattle from a dairy farm in the east-
ern Netherlands during April 2012–
April 2013.
The dairy farm is the only location 
in the Netherlands where monitoring 
for biting midges was continuously 
conducted during the 2011–2013 SBV 
epidemic and where SBV RNA was 
detected in biting midges caught dur-
ing 2011–2012 (6,7). The dairy herd 
comprised 110 animals: 60 milking 
cows (average age 4.0 years) and 50 
heifers (average age 1.5 years) and 
calves (<1.0 year of age). No clini-
cal signs or symptoms of SBV infec-
tion were observed in any of the cattle 
at the end of 2011 or during 2012. 
However, during the study period, 3 
calves were stillborn, none of which 
had the characteristic malformations 
observed after SBV infection. Gross 
pathology confirmed that the calves 
did not have SBV infection, and all 
tissue samples were negative for SBV 
by reverse transcription PCR.
During the 12-month study, we 
obtained 4 blood samples from all 
animals in the herd. A virus neutral-
ization test (VNT) was used to test 
the samples for antibodies (8). For 
optimal specificity and sensitivity, the 
VNT cutoff dilution was set at 1:8. 
Test dilutions ranged from 1:4–1:512. 
All samples were tested in duplicate; 
titers were determined using the Reed-
Münch method and expressed on a 
log2 scale. 
Blood samples were first obtained 
from the herd on April 19, 2012, after 
retrospective detection of SBV RNA in 
biting midges that had been collected 
from the farm on September 14, 2011 
(6). The remaining 3 blood samples for 
each animal were collected on Septem-
ber 17, 2012; December 9, 2012; and 
April 23, 2013 (5, 8, and 12 months, 
respectively, after the first collection). 
SBV VNT results for the initial blood 
samples were positive for all cows ≥1 
year of age and for all but four 6-month-
old calves. One year later, blood sam-
ples for 98% of the cows ≥1 year of 
age and 50% of the cows <1 year of 
age were SBV seropositive. During the 
year, the mean log2 VNT titer of the 
adult cows dropped from 8.3 to 6.7.
It can be assumed that cows ≥1 
year of age became infected with SBV 
around the time SBV-infected Culicoi-
des biting midges were detected on the 
farm in September 2011 (6). Thus, at 
least 19 months after natural infection, 
these cows were probably protected 
against SBV when re-exposed to the vi-
rus. Of all cattle tested, 11 heifers sero-
converted between April 2012 and Sep-
tember 2012, and 1 cow seroconverted 
between the September and December 
2012 samplings. The low rate of sero-
conversion was matched by a 6× lower 
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